This is so awesome. Congratulations to all the researchers involved. Now make the treatment affordable, government orgs, that’s your job. Sickle cell mostly affects those in low income populations who already struggle with access to affordable healthcare.


F.D.A. Approves Sickle Cell Treatments, Including One That Uses CRISPR (Published 2023)
People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit their reach.

